Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
International Seaways Inc. stock logo
INSW
International Seaways
$37.04
+1.5%
$37.16
$27.20
$60.70
$1.83B0.05757,666 shs377,044 shs
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$536.81
+2.2%
$553.45
$476.49
$1,211.20
$57.99B0.311.15 million shs857,538 shs
RLI Corp. stock logo
RLI
RLI
$71.64
-0.8%
$74.30
$68.50
$91.15
$6.58B0.7384,049 shs278,522 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
International Seaways Inc. stock logo
INSW
International Seaways
-1.56%-6.64%-1.40%+9.85%-38.15%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
+0.77%+2.56%+6.44%-14.91%-50.05%
RLI Corp. stock logo
RLI
RLI
+1.54%-1.92%-5.95%-10.50%+2.75%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
International Seaways Inc. stock logo
INSW
International Seaways
4.3179 of 5 stars
3.53.02.50.01.22.51.9
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4.936 of 5 stars
4.45.01.72.32.71.71.9
RLI Corp. stock logo
RLI
RLI
3.5301 of 5 stars
1.14.03.31.82.41.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
International Seaways Inc. stock logo
INSW
International Seaways
3.00
Buy$51.3338.61% Upside
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2.80
Moderate Buy$813.5751.55% Upside
RLI Corp. stock logo
RLI
RLI
2.14
Hold$78.609.72% Upside

Current Analyst Ratings Breakdown

Latest INSW, REGN, and RLI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/30/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
6/9/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$950.00 ➝ $800.00
6/5/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$633.00 ➝ $560.00
6/2/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$700.00 ➝ $650.00
6/2/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$800.00 ➝ $600.00
6/2/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$958.00 ➝ $755.00
5/30/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/30/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeModerate Buy ➝ Hold$662.00
5/30/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$700.00 ➝ $580.00
5/27/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Sector Perform$943.00 ➝ $662.00
5/8/2025
International Seaways Inc. stock logo
INSW
International Seaways
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$48.00 ➝ $48.00
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
International Seaways Inc. stock logo
INSW
International Seaways
$951.61M1.92$10.96 per share3.38$37.73 per share0.98
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$14.20B4.08$47.09 per share11.40$268.50 per share2.00
RLI Corp. stock logo
RLI
RLI
$1.77B3.71$2.99 per share23.93$16.61 per share4.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
International Seaways Inc. stock logo
INSW
International Seaways
$416.72M$6.475.737.96N/A37.39%14.98%10.74%8/6/2025 (Estimated)
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$4.41B$39.2813.6714.121.9131.94%15.27%11.93%7/30/2025 (Estimated)
RLI Corp. stock logo
RLI
RLI
$345.78M$3.0423.5923.11N/A16.22%16.26%4.63%7/28/2025 (Estimated)

Latest INSW, REGN, and RLI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/28/2025Q2 2025
RLI Corp. stock logo
RLI
RLI
$0.75N/AN/AN/AN/AN/A
5/8/2025Q1 2025
International Seaways Inc. stock logo
INSW
International Seaways
$0.59$0.80+$0.21$1.00$176.49 million$178.34 million
4/29/2025Q1 2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$8.83$8.22-$0.61$7.27$3.40 billion$3.03 billion
4/23/2025Q1 2025
RLI Corp. stock logo
RLI
RLI
$0.88$0.92+$0.04$0.68$442.20 million$36.73 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
International Seaways Inc. stock logo
INSW
International Seaways
$0.481.30%N/A7.42%N/A
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$3.520.66%N/A8.96%N/A
RLI Corp. stock logo
RLI
RLI
$0.640.89%N/A21.05%51 Years

Latest INSW, REGN, and RLI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/9/2025
International Seaways Inc. stock logo
INSW
International Seaways
quarterly$0.121.3%6/12/20256/12/20256/26/2025
5/14/2025
RLI Corp. stock logo
RLI
RLI
quarterly$0.160.9%5/30/20255/30/20256/20/2025
5/20/2025
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
quarterly$0.880.6%5/20/20255/20/20256/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
International Seaways Inc. stock logo
INSW
International Seaways
0.29
2.76
2.75
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
0.09
4.93
4.03
RLI Corp. stock logo
RLI
RLI
0.06
0.35
0.35

Institutional Ownership

CompanyInstitutional Ownership
International Seaways Inc. stock logo
INSW
International Seaways
67.29%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
83.31%
RLI Corp. stock logo
RLI
RLI
77.89%

Insider Ownership

CompanyInsider Ownership
International Seaways Inc. stock logo
INSW
International Seaways
2.00%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7.02%
RLI Corp. stock logo
RLI
RLI
2.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
International Seaways Inc. stock logo
INSW
International Seaways
2,82449.34 million48.35 millionOptionable
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
15,106107.96 million100.39 millionOptionable
RLI Corp. stock logo
RLI
RLI
1,14791.77 million89.79 millionOptionable

Recent News About These Companies

Brokerages Set RLI Corp. (NYSE:RLI) Price Target at $78.60
Insider Sale: Director at $COCO Sells 3,900 Shares
3 Leading Dividend Stocks Yielding Up To 6.6%

New MarketBeat Followers Over Time

Media Sentiment Over Time

International Seaways stock logo

International Seaways NYSE:INSW

$37.03 +0.56 (+1.52%)
As of 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

International Seaways, Inc. owns and operates a fleet of oceangoing vessels for the transportation of crude oil and petroleum products in the international flag trade. It operates in two segments: Crude Tankers and Product Carriers. As of December 31, 2023, the company owned a fleet of 73 vessels. It serves independent and state-owned oil companies, oil traders, refinery operators, and international government entities. The company was formerly known as OSG International, Inc. and changed its name to International Seaways, Inc. in October 2016. International Seaways, Inc. was incorporated in 1999 and is headquartered in New York, New York.

Regeneron Pharmaceuticals stock logo

Regeneron Pharmaceuticals NASDAQ:REGN

$536.81 +11.81 (+2.25%)
As of 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

RLI stock logo

RLI NYSE:RLI

$71.64 -0.58 (-0.80%)
As of 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RLI Corp., an insurance holding company, underwrites property and casualty insurance. Its Casualty segment provides commercial and personal coverage products; and general liability products, such as coverage for third-party liability of commercial insureds, including manufacturers, contractors, apartments, and mercantile. It also offers coverages for security guards and environmental liability for underground storage tanks, contractors and asbestos, and environmental remediation specialists; and professional liability coverages for errors and omission coverage for small to medium-sized design, technical, computer, and miscellaneous professionals. This segment provides commercial automobile liability and physical damage insurance to local, intermediate and long haul truckers, public transportation entities, and other types of specialty commercial automobile risks; incidental and related insurance coverages; inland marine coverages; management liability coverages, such as directors and officers liability insurance, fiduciary liability and coverages, employment practice liability, and for various classes of risks, including public and private businesses; and home business insurance products. The company's Property segment offers commercial property, cargo, hull, protection and indemnity, marine liability, inland marine, homeowners' and dwelling fire, and other property insurance products. Its Surety segment offers commercial surety bonds for medium to large-sized businesses; small bonds for businesses and individuals; and bonds for small to medium-sized contractors. The company also engages in various reinsurance coverages. It markets its products through branch offices, wholesale and retail brokers, carrier partners, and underwriting and independent agents. RLI Corp. was incorporated in 1965 and is headquartered in Peoria, Illinois.